The Global AMR R&D Hub consults, cooperates and collaborates with different partners globally, including international organisations, existing R&D initiatives, industry, researchers, non-governmental organisations and governments.
Formal collaboration between relevant players and the Global AMR R&D Hub may be needed and the Collaboration Framework provides the guidance and mechanism for this.
Who we are working with
ICARS’ mission is to partner with low- and middle-income countries (LMICs) in their efforts to mitigate AMR. This is done by co-developing tailored solutions with LMIC governments and researchers, who then implement them on the ground using ICARS funding and expertise, building on AMR National Action Plans. ICARS was initiated by the Danish government in 2018 and is already co-developing projects in 10 countries. ICARS is currently embedded in the Danish Ministry of Health but is expected to become independent by the fall of 2021, with its own Board of Directors.
STAR-IDAZ International Research Consortium (IRC) on Animal Health is a global initiative involving 29 research funders and programme owners from 19 countries with the objective of coordinating research programmes at international level to accelerate the delivery of disease control tools and strategies.
EU-JAMRAI is a European Joint Action on Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HCAI) that was active from 2018 through 2021. It brought together 44 partners and more than 40 stakeholders, including the Global AMR R&D Hub. The mission was to foster synergies among EU Member States by developing and implementing effective One Health policies to fight the rising threat of AMR and to reduce HCAI. EU-JAMRAI was co-funded by the Health Programme of the European Union under Grant Agreement No. 761296.
PAR Foundation, or The Foundation to Prevent Antibiotic Resistance, is an independent foundation backed by philanthropic donations. PAR Foundation grants financial support for research, education and information efforts that aim to prevent antibiotic resistance. Their strategy is focused on maximizing resource-effective impact, which makes it important to be able to identify promising areas that are neglected by other funders.
AMR Insights is a network-based organization that informs and connects relevant professions around the globe with the aim of curbing antimicrobial resistance.
Public consultation on global coordination & collaboration needs
In 2019, views were sought on the Global AMR R&D Hub’s draft Collaboration Framework. The draft Framework outlined a much larger role for the Hub in improving coordination and collaboration of AMR R&D. After assessing the results of the public consultation, it was decided that the Global AMR R&D Hub would focus on the launch and development of the Dynamic Dashboard and the collaboration that will form from this work.
Valuable insights were received from the public consultation on the draft Collaboration Framework. A summary of the the anonymized and aggregated results are provided below. The Global AMR R&D Hub is committed to disseminating and advocating for the key messages that arose during this process.